Edinburgh Clinical Trials

The TARGET-CTCA Trial

Troponin in Acute chest pain to Risk stratify and Guide EffecTive use of Computed Tomography Coronary Angiography

TARGET-CTCA is a prospective, randomised, open label with blinded endpoint evaluation (PROBE) trial of CTCA in the diagnosis and management of patients who attend hospital with acute chest pain and intermediate high-sensitivity cardiac troponin concentrations.

About the Trial

Target CTCA about the trial image
TARGET-CTCA is a non-commercial trial sponsored by a partnership of the University of Edinburgh and NHS Lothian called ACCORD and funded by the British Heart Foundation (BHF).